HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


U.S. beauty growth

This article was originally published in The Rose Sheet

Executive Summary

The demand for cosmetic and toiletry chemicals in the U.S. is expected to rise 5.4% per year to $7.6 bil. in 2010, according to industry research company The Freedonia Group. The growth will be driven by favorable trends in demographics as well as "consumer desires to offset the effects of aging, and preferences for 'natural'" products, the Cleveland-based company says. As a result, "active and plant-derived ingredients will benefit the most," firm adds. Growing demand for active ingredients, such as amino acids and peptides, "will be propelled by continued gains in cosmeceuctical skin care products and high-value additives such as nanoscale ingredients," firm reports. Male grooming, ethnic products, anti-aging and products for consumers 50+ are poised to achieve "rapid" growth through 2010...

You may also be interested in...

Male Grooming Promos Capture Webby Award Nominations

Nominees for the 11 Annual Webby Awards' Best Beauty and Cosmetics Site of the Year highlight the creativity of online promotions targeting young men

Tecentriq Disappoints In Post-Surgery Bladder Cancer

Failure is a knock-back for the blockbuster product, but Tecentriq has many more opportunities for trial success in 2020.

UK-Based GMDN Endorsed As US Preferred Method For Categorizing High-Risk Implants

While the EU has selected the CND system as the basis for its nomenclature, GMDN is becoming increasingly valued on the US and international scene. How does it see its latest role panning out globally?




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts